EN6
Based on 5 publication(s) in Google Scholar
EN6 is a small-molecule in vivo autophagy activator that covalently targets cysteine 277 in the ATP6V1A subunit of the lysosomal v-ATPase. EN6-mediated modification of ATP6V1A uncouples v-ATPase from Rag, leading to inhibition of mTORC1 signalling, increased lysosomal acidification, and activation of autophagy. EN6 also scavenges TDP-43 aggregates (causative agents of frontotemporal dementia) in a lysosome-dependent manner.
For research use only. We do not sell to patients.
- Purity: 99.42%
- CAS No.: 1808714-73-9
- Formula: C19H14F2N4O2
- Molecular Weight:368.34
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
Publications Citing Use of MedChemExpress (MCE) EN6
More-
Cell Imaging/Staining
-
WB
-
IF
-
IF
-
Histological Imaging/Staining
Biological Activity
EN6 (50 μM; 1, 4, 8 h) increases the levels of LC3BII, and triggers formation of LC3 puncta in a time- and dose-dependent manner, in HEK293A cells[1].
?
EN6 leads to significant increases in the number autophagosomes and autolysosomes in HEK293A cells[1].
?
EN6 (25 μM; 1 h) blocks mTORC1 lysosomal localization and activation in HEK293A cells[1].
?
EN6 (50 μM; 4 h) activates the v-ATPase and lysosome acidification in HEK293A cells[1].
?
EN6 (25 μM; 7 h) promotes autophagic clearance of protein aggregates in IPTG-inducible GFP-TDP43 U2OS osteosarcoma cell line model[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HEK293A cells
-
Concentration:50 μM
-
Incubation Time:1, 4, 8 h
-
Result:Time- and dose-dependently triggered formation of LC3 puncta and increased the levels of LC3BII.
-
Cell Line:HEK293A cells
-
Concentration:25 μM
-
Incubation Time:1 h
-
Result:Led to complete inactivation of mTORC1 signaling, as shown by reduced levels of phosphorylated canonical substrates, S6 kinase 1 (S6K1), 4EBP1, and ULK1.
-
Cell Line:HEK293A cells
-
Concentration:50 μM
-
Incubation Time:4 h
-
Result:Led to significantly increased acidification of the lysosome in HEK293A cells, and this heightened acidification was blocked by BafA1.
-
Cell Line:IPTG-inducible GFP-TDP43 U2OS osteosarcoma cell line model
-
Concentration:25 μM
-
Incubation Time:7 h
-
Result:Reduced IPTG-induced TDP43 aggregates by 75 %.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Six-week-old male C57BL/6 mice[1].
-
Dosage:50 mg/kg
-
Administration:Intraperitoneal injection; single
-
Result:Significantly inhibited mTORC1 signaling in both skeletal muscle and heart, as demonstrated by reduced phosphorylation of S6, 4EBP1 and ULK1.
Strongly activated autophagy as shown by heightened LC3BII levels and reduced p62 levels.
Chemical Information
-
CAS No. 1808714-73-9
-
Appearance Solid
-
Molecular Weight 368.34
-
Formula C19H14F2N4O2
-
Color White to off-white
-
SMILES
O=C(C1=CN(C2=CC=CC=C2F)N=C1)NC3=CC=C(F)C(NC(C=C)=O)=C3
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 2 years -20°C 1 year
Publications (5)
-
Journal Impact Factor
-
Most Recent
-
Adv Sci (Weinh)
Exploring the Link Between Autophagy-Lysosomal Dysfunction and Early Heterotopic Ossification in Tendons. [Abstract]2024 May 13:e2400790. PMID: 38741381
EN6 purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2024 May 13:e2400790. [Abstract]
EN6 (50 mg/kg; every other day for 14 d) significantly impaired the level of extracellular matrix calcification of tendon fibroblasts.
EN6 purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2024 May 13:e2400790. [Abstract]
EN6 (50 mg/kg; every other day for 14 d) reduced extracellular vesicles specific protein CD9 and autolysosomes associated LC3 and LAMP1 in tendon fibroblasts treated with IL‐1β+TNF‐α.
EN6 purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2024 May 13:e2400790. [Abstract]
EN6 (50 mg/kg; every other day) decreased the green fluorescent signal in the Achilles tendon of C57BL/6J mice, suggesting that autophagosomes were hydrolyzed after binding to lysosomes and autophagic flux was restored. Impaired autophagic flux (yellow arrows) and normal autophagic flux (red arrows).
EN6 purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2024 May 13:e2400790. [Abstract]
EN6 (50 mg/kg; every other day) significantly decreased the expression level of LC3B and P62 in the Achilles tendons of C57BL/6J mice, suggesting restoration of autophagic flux.
EN6 purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2024 May 13:e2400790. [Abstract]
EN6 (50 mg/kg; every other day) significantly reduced heterotopic ossification (HO) in tendons of C57BL/6J mice at 1 and 3 weeks after surgery.
-
Proc Natl Acad Sci U S A
Endocytosis triggers V-ATPase-SYK-mediated priming of cGAS activation and innate immune response. [Abstract]2022 Oct 25;119(43):e2207280119. PMID: 36252040 -
Neurochem Res
3BDO Alleviates Seizures and Improves Cognitive Function by Regulating Autophagy in Pentylenetetrazol (PTZ)-Kindled Epileptic Mice Model. [Abstract]2022 Dec;47(12):3777-3791. PMID: 36243819 -
-
Solvent & Solubility
DMSO : 5 mg/mL (13.57 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Ethanol : 1.11 mg/mL (3.01 mM; ultrasonic and warming and heat to 60°C)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
For the following dissolution methods, please prepare the working solution directly:
It is recommended to prepare fresh solutions and use them promptly within a short period of time.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 50% PEG300 50% Saline
Solubility: 10 mg/mL (27.15 mM); Suspended solution; Need ultrasonic
Purity & Documentation
-
Data Sheet (277 KB)
-
SDS (396 KB)
- English - EN (396 KB)
- Français - FR (396 KB)
- Deutsch - DE (396 KB)
- Norwegian - NO (396 KB)
- Español - ES (396 KB)
- Swedish - SV (396 KB)
- Italian - IT (396 KB)
- Korean - KR (396 KB)
- Portuguese - PT (396 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| Ethanol / DMSO | 1 mM | 2.7149 mL | 13.5744 mL | 27.1488 mL | 67.8721 mL |
| DMSO | 5 mM | 0.5430 mL | 2.7149 mL | 5.4298 mL | 13.5744 mL |
| 10 mM | 0.2715 mL | 1.3574 mL | 2.7149 mL | 6.7872 mL |